Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

Research and Innovation Action · Running

ISIDORe Integrated Services for Infectious Disease Outbreak Research

Coordinator
European Research Infrastructure on Highly Pathogenic Agents, Belgium
Runs
1 February 2022 to 31 July 2025
Status
Running
EU funding
€21.0m
Total cost
€21.0m
Partners
159 organisations in 32 countries
Type
Research and Innovation Action
Grant agreement
101046133

What the project is doing

In the project's own words, from its summary on CORDIS.

The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest and most diverse research and service providing instrument to study infectious diseases in Europe, from structural biology to clinical trials. Giving scientists access to the whole extent of our state of the art facilities, cutting edge services, advanced equipment and expertise, in an integrated way and with a common goal, will enable or accelerate the generation of new knowledge and intervention tools to ultimately help control SARS CoV 2 in particular, and epidemic prone pathogens in general, while avoiding fragmentation and duplication among European initiatives.

Such a global and interdisciplinary approach is meant to allow the implementation of user projects that are larger, more ambitious and more impactful than the EU supported transnational activities that the consortium is used to run. Our proposition is ambitious but achievable in a timely fashion due to the relevance and previous experience of the partners that we have gathered and that have complementary fields of expertise, which addresses the need for an interdisciplinary effort.

Leveraging all these existing strengths to develop synergies will create an additional value and enhance Europe capacity for controlling emerging or re emerging and epidemic infectious diseases, starting with the COVID 19 pandemic. Such a global and coordinated approach is consistent with the recommendations of the One Health concept and necessary to make significant contributions to solving complex societal problems like epidemics and pandemics.

Topics

Who is involved

OrganisationCityCountryRole
European Research Infrastructure on Highly Pathogenic AgentsBruxelles / BrusselBelgiumCoordinator
Biobanks and Biomolecular Resources Research Infrastructure Consortium (bbmri-Eric)GrazAustriaParticipant
Joanneum Research Forschungsgesellschaft MbhGrazAustriaParticipant
Medizinische Universitaet WienWienAustriaParticipant
Medizinische Universitat GrazGrazAustriaParticipant
Vienna Biocenter Core Facilites GmbHWienAustriaParticipant
Commonwealth Scientific and Industrial Research OrganisationActon ActAustraliaParticipant
Brac UniversityDhakaBDParticipant
Avia-Gis NVZoerselBelgiumParticipant
Jrc -Joint Research Centre- European CommissionBruxelles / BrusselBelgiumParticipant
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
Universite De LiegeLiegeBelgiumParticipant
Vib VzwZwijnaarde - GentBelgiumParticipant
Ministere De La SanteOuagadougouBurkina FasoParticipant
Roumen Tsanev Institute of Molecular Biology Bulgarian Academy of SciencesSofiaBulgariaParticipant
Eidgenoessisches Departement Des InnernBernSwitzerlandParticipant
Fondazione per L'istituto Di Ricerca in BiomedicinaBellinzonaSwitzerlandParticipant
Scuola Universitaria Professionale Della Svizzera ItalianaMannoSwitzerlandParticipant
Swiss Clinical Trial Organisation (scto)BernSwitzerlandParticipant
Universitat BaselBaselSwitzerlandParticipant
Universitat ZurichZurichSwitzerlandParticipant
Vaccine Formulation Institute(ch)ltdPlan Les OuatesSwitzerlandParticipant
Biotechnologicky Ustav Av Cr VviVestecCzechiaParticipant
Masarykova univerzitaBrnoCzechiaParticipant
Univerzita KarlovaPraha 1CzechiaParticipant
Univerzita Palackeho V OlomouciOlomoucCzechiaParticipant
Ustav Molekularni Genetiky Av Cr V.v.i.Praha 4CzechiaParticipant
Bernhard-Nocht-Institut Fuer TropenmedizinHamburgGermanyParticipant
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
European Infrastructure of Open Screening Platforms for Chemical Biology European Research Infrastucture Consortium (eu-Openscreen Eric)BerlinGermanyParticipant
European Molecular Biology LaboratoryHeidelbergGermanyParticipant
European Vaccine Initiative eVHeidelbergGermanyParticipant
Forschungsverbund Berlin eVBerlinGermanyParticipant
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eVMunchenGermanyParticipant
Friedrich Loeffler Institut - Bundesforschungsinstitut Fuer TiergesundheitGreifswald-Insel RiemsGermanyParticipant
Helmholtz-Zentrum Fur Infektionsforschung GmbHBraunschweigGermanyParticipant
Hits GgmbhHeidelbergGermanyParticipant
Infrafrontier EricNeuherbergGermanyParticipant
InSCREENeX GmbHBraunschweigGermanyParticipant
Johann Wolfgang Goethe-Universitaet Frankfurt Am MainFrankfurt Am MainGermanyParticipant
Julius Kuhn-Institut Bundesforschungsinstitut Fur KulturpflanzenQuedlinburgGermanyParticipant
Kks-Netzwerk eV -Netzwerk Der Koordinierungszentren Fur Klinische StudienBerlinGermanyParticipant
Leibniz-Institut Dsmz-Deutsche Sammlung Von Mikroorganismen Und Zellkulturen GmbHBraunschweigGermanyParticipant
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eVMunchenGermanyParticipant
Philipps Universitaet MarburgMarburgGermanyParticipant
Universitaet LeipzigLeipzigGermanyThird party
Universitatsklinikum JenaJenaGermanyThird party
Aarhus UniversitetAarhus CDenmarkParticipant
Danmarks Tekniske UniversitetKongens LyngbyDenmarkParticipant
Statens Serum InstitutKobenhavn SDenmarkParticipant
Idryma Iatroviologikon Ereunon Akademias AthinonAthinaGreeceParticipant
Idryma Technologias Kai ErevnasIrakleioGreeceParticipant
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainParticipant
Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I SunyerBarcelonaSpainParticipant
Fundacio Hospital Universitari Vall D'hebron - Institut De RecercaBarcelonaSpainParticipant
Fundacion Centro De Excelencia En Investigacion De Medicamentos Innovadores En AndaluciaArmilla GranadaSpainParticipant
Fundacion Para La Investigacion Biomedica Del Hospital Universiatrio La PazMadridSpainParticipant
Institut De Investigacio En Ciencies De La Salut Germans Trias I PujolBadalona BarcelonaSpainParticipant
Institut De Recerca I Tecnologia AgroalimentariesCaldes De Montbui BarcelonaSpainParticipant
Abo AkademiAboFinlandParticipant

And 99 more organisations. Full list on CORDIS.

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI